$470 Million is the total value of Capital Advantage, Inc.'s 40 reported holdings in Q1 2023. The portfolio turnover from Q4 2022 to Q1 2023 was 36.4% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
VCIT | New | Vanguard Intermediate Term Corporate ETFetf | $36,188,211 | – | 448,874 | +100.0% | 7.70% | – |
FNDF | Buy | Schwab Fundamental Intl Large Co ETFetf | $23,588,665 | +8.5% | 747,660 | +0.0% | 5.02% | +2.9% |
XLP | Buy | Consumer Staples SPDR ETFetf | $19,458,435 | +1.9% | 259,619 | +1.3% | 4.14% | -3.5% |
VYMI | Buy | Vanguard Intl High Dividend ETFetf | $16,142,539 | +6.8% | 257,334 | +1.4% | 3.43% | +1.2% |
VBR | Buy | Vanguard Small Cap Value Index ETFetf | $10,855,697 | +0.2% | 69,677 | +2.2% | 2.31% | -5.0% |
SCHM | Buy | Schwab US Mid Cap ETFetf | $5,288,449 | +3.8% | 79,192 | +2.0% | 1.12% | -1.7% |
WDAY | New | Workday Incequities | $4,540,671 | – | 22,412 | +100.0% | 0.97% | – |
EFA | Buy | iShares MSCI EAFE Indexetf | $2,097,383 | +10.6% | 29,090 | +0.7% | 0.45% | +4.7% |
VYM | New | Vanguard High Dividend Yield ETFetf | $1,081,989 | – | 10,272 | +100.0% | 0.23% | – |
PFE | Buy | Pfizer Incequities | $1,014,202 | -17.2% | 24,797 | +3.7% | 0.22% | -21.5% |
INTC | Buy | Intel Corpequities | $653,300 | +33.2% | 19,737 | +6.3% | 0.14% | +26.4% |
SCHW | Buy | Charles Schwab Corpetf | $547,923 | -38.0% | 10,958 | +3.3% | 0.12% | -40.9% |
VZ | Buy | Verizon Communications Incequities | $543,347 | +4.0% | 13,704 | +3.3% | 0.12% | -0.9% |
T | Buy | AT&T Incequities | $511,732 | +8.2% | 26,056 | +1.4% | 0.11% | +2.8% |
PCG | New | PG&E Corpequities | $245,160 | – | 15,199 | +100.0% | 0.05% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-05-05
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
Microsoft Corp | 39 | Q3 2023 | 1.2% |
Chevron Corp | 39 | Q3 2023 | 1.0% |
Facebook Inc Class A | 39 | Q3 2023 | 1.3% |
AT&T Inc | 39 | Q3 2023 | 0.6% |
Pfizer Incorporated | 39 | Q3 2023 | 0.3% |
Cisco Systems Inc | 39 | Q3 2023 | 0.3% |
Verizon Communications Inc | 39 | Q3 2023 | 0.3% |
iShares Russell 2000 ETF | 38 | Q2 2023 | 1.4% |
Vanguard Dividend Appreciation ETF | 37 | Q3 2023 | 8.4% |
Merck & Co Inc | 37 | Q2 2023 | 0.4% |
View Capital Advantage, Inc.'s complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-05-14 |
13F-HR | 2024-01-23 |
13F-HR | 2023-10-30 |
13F-HR | 2023-08-07 |
13F-HR | 2023-05-05 |
13F-HR | 2023-01-24 |
13F-HR | 2022-10-31 |
13F-HR | 2022-07-21 |
13F-HR | 2022-05-10 |
13F-HR | 2022-01-21 |
View Capital Advantage, Inc.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.